Course Information

BUS341 Drug Discovery and Development
Summer 2019

This course will exam the modern biopharmaceutical industry, one of the most innovative and dynamic sectors in the developed economy. Topics to include the science and innovation that drives the increases in our quality of life as well as further drug innovation and discovery.

Students will gain a thorough understanding of the biopharmacuetical industry and its' dependency on political, legal and regulatory factors. Additionally, we will examine the industry's historical background, organization structure, R&D concerns, the regulatory processes, intellectual property, pricing and reimbursement, sales and marketing, and business ethics as well as critical issues facing healthcare, such as cost containment pressures, competition from generic products, and globalization. This course will further prepare students interested in pursuing employment opportunities in the biopharmaceutical industry.

Student Learning Objectives

It is expected that you will complete this course understanding the essential aspects of pharmaceutical research, discovery, and development, regulatory parameters, pricing and promotional strategies, and critical issues the industry faces in the 21^st century

Previously, this course was taught in a traditional F2F setting. I have taught this course several times in the F2F setting with similar outcomes and assignments; however, this will be the first time teaching the course on-line. Prior Instructors have collaborated on content and strategies contained in this course and are interested in creating and maintaining highest level of instruction.

Course begins with an introduction to biopharmaceutical industry which can be used and applied to other industries especially those which rely on continuous innovations for survival. Students can use information provided to identify opportunities in the biopharmaceutical industry as well as best methods and strategies needed to facilitate an understanding of growth and investment opportunities provided in this industry.

First QLT Objective Showcased

Section 2: Assessment of Student Learning

2.1: All Student Learning Objectives/Outcomes (SL)s) are specific, well-defined and measurable.

Description of QLT Course Design

To meet the standards for Section 2: Assessment and Evaluation of Student Learning,

2.1 Following learning outcomes for the course encompass the modules and assignments noted in the Syllabi and are outlined below:

Explain the industrial organization of biopharmaceutical firms and present case analysis defining specific example of biopharmaceutical firm.
Define the role of R&D innovations in the long-term success of biopharmaceutical firms.
Enumerate intellectual property and the patent system as it pertains to the biopharmaceutical industry.
Describe major promotional channels and the effectiveness of each.
Outline and summarize the basic pricing principles and strategies used in the biopharmaceutical industry.
Explain the role of a third party payer (i.e., insurance) for biopharmaceuticals.
Describe basic evaluation techniques of new biopharmaceutical products.
Be prepared to discuss the importance of ethics in the success of a biopharmaceutical firm.
Explain the role of generic drugs.
Evaluate public policies toward the biopharmaceutical industry.

Second QLT Objective Showcased

Section 2: Assessment of Student Learning

2.4: The assessment instruments (e.g., rubrics, grading sheets) are detailed and appropriate to the student work and respective outcomes being assessed.

Description of QLT Course Design

To meet the standards for Section 2: Assessment and Evaluation of Student Learning

2.4 Detailed, measureable rubrics were developed, appropriate to the student work and aligned to outcomes being assessed.

Rubric Hamermesh.png

Instructor Contact Information

CSUCI Email: david.damron@csuci.edu

Office Hours: Weekly Chat by Appointment only to function as Office Hours

Group Topic: